Search information pages
This page includes information about the aims and scope of ARIC, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Antimicrobial Resistance and Infection Control is a global forum for reports encompassing all aspects of resistance development and prevention of health-care associated infections in all health-care settings.
Andreas Voss - Canisius-Wilhelmina Hospital and Radboud University Nijmegen Medical Centre, Netherlands
Didier Pittet - University of Geneva Hospitals Switzerland
Jan A Kluytmans - Amphia Hospital, Breda & Free University Medical Centre, Netherlands
Antimicrobial Resistance and Infection Control aims to be a global forum for all those working on the prevention, diagnostic and treatment of health-care associated infections and antimicrobial resistance development in all health-care settings. Infection Control wishes to cover a broad spectrum of 'preeminent practices' and 'best available data' to the 'best interventional and translational research' and innovative (technical) developments in the field of infection control.
Antimicrobial Resistance and Infection Control believes that a better understanding of the factors contributing to the development and spread of multi-drug resistance pathogens, possibilities to prevent transmission and infections and insight into the difference between developed countries and countries with limited resources are key-factors to find future solutions. Antimicrobial Resistance and Infection Controlneeds to combine best practices, experience and latest research results from around the globe to overcome the challenge posed by healthcare-associated infections. Antimicrobial Resistance and Infection Control welcomes all manuscripts related to the filed of HAI prevention and infection control. Some examples are listed below:
- Prevention of health-care associated infection in hospitals.
- Infection control and antimicrobial-resistance in high-risk settings (e.g. ICUs).
- HAI prevention and antimicrobial-resistance in special settings e.g. long-term care facilities.
- Infection control and antimicrobial-resistance in community settings.
- Special problems with Infection control and antimicrobial-resistance in resource-limited countries.
All articles published by ARIC are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in ARIC are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
Open access publishing is not without costs. ARIC therefore levies an article-processing charge of £1115/$1685/€1305 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.
All articles published in ARIC are included in:
- PubMed Central
BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in ARIC will be available.
Publication and peer review process
Antimicrobial Resistance and Infection Controls considers the following types of articles:
- Research:reports of data from original research.
- Reviews: of any topic within the scope of the journal. They may be either invited by the editor or unsolicited. Plenary lectures from Conferences and specialized meetings are welcomed. These may include the slides and videos that were used in the original presentation. Authors and conference organizers are encouraged to discuss proposals with the Editor at an early stage. All reviews will be peer-reviewed.
- Letter to the Editor: These can take several forms. For example, a substantial critique or re-analysis of a previously published article, a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers. Please consult the Editor prior to submission if in doubt.
- Case reports - reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Reports may suggest the need for a change in practice or thinking in terms of diagnosis or prognosis, but not in terms of preventative or therapeutic intervention, which require stronger evidence.
- Short reports: brief reports of data from original research, usually about 1500 words.
- Commentaries: short, focused and opinionated articles on any subject within the journal's scope. These articles focus on specific issues and are about 800 words.
- Discussion of articles published in the journal is encouraged, and these contributions will be included in Readers' Comments, accessed from the web page on which the article is displayed. These comments are subject to editing and remain in the Archives associated with the specific article to which they refer.
Manuscripts will be reviewed by internationally recognized experts in the field, selected in part from the Editorial Board. Reviews will be rapid and the suitability of a manuscript for publication will be assessed solely on criteria of scientific excellence. Final decisions will be made by the Editor-in-Chief and may include accept, reject, accept following minor revision and resubmit after major revision and further review.
Edited by Andreas Voss, Antimicrobial Resistance and Infection Control is supported by an expert Editorial Board.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Antimicrobial Resistance and Infection Control, a personalized section of the site.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
ARIC will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. For further information, please contact us.
All manuscripts submitted to Antimicrobial Resistance and Infection Control should adhere to BioMed Central's editorial policies.
Citing articles in ARIC
Articles in ARIC should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Antimicrob Resist Infect Control [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Antimicrob Resist Infect Control 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in ARIC?
ARIC's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
ARIC offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles are published with their final citation immediately upon acceptance in a provisional PDF form. The article will subsequently be published in both fully browsable web form, and as a formatted PDF; the article will then be available through ARIC and BioMed Central.
Online publication in ARIC gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other papers).
Promotion and press coverage
Articles published in ARIC are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on ARIC's pages and on the BioMed Central homepage.
In addition, articles published in ARIC may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in ARIC. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in ARIC retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.